| Todd C. Zion SMARTCELLS, INC. |
Todd C. Zion founded SmartCells, Inc. in 2003 to develop SmartInsulin™,
the first glucose-regulated, injectable formulation for treating diabetes.
As SmartCells’ president and CEO, He was instrumental in raising $10
million in equity financing from individual investors and $10 million in
grants to support research and clinical development. In December 2010,
Merck and Co. acquired SmartCells for over $500 million in cash and
clinical milestone payments. He developed the SmartInsulin™ technology
as part of his doctoral thesis work at MIT. Prior to enrolling at MIT,
he worked as a polymer development engineer at Eastman Kodak. He
now enjoys advising technology entrepreneurs through MIT’s Venture
Mentoring Service. He also serves on a number of advisory boards including
those of the Beth Israel Deaconess Medical Center and the CNY
Biotech Accelerator.
72 Nanepashemet St.
Marblehead, MA 01945
857 389-2273
todd@toddzion.com